This review focuses on the synthetic and computer-assisted drug design (CADD) approaches made by various research groups for the development of newer antitrypanosomal agents having improved efficacy and oral bioavailability. The current research also endeavors [10] to investigate the relationship between the various physiochemical parameters and anti-trypanosomal activity that may be helpful in development of potent anti-trypanosomal agents against sleeping sickness.